Profile: Marc Mansour Ascending

After 14 years in startup wilderness, Halifax biotech company Immunovaccine (IMV) and its Chief Operating Officer Dr. Marc Mansour are exactly where they need to be. With data from clinical trials demonstrating the effectiveness of the IMV patented vaccine-delivery system, the company may soon see its technology lessening everyday scourges like flu and cancer as well as uncommon diseases, such